NOV 20, 2019 7:18 PM PST

Mining 'Junk' DNA for New Cancer Therapeutics

WRITTEN BY: Carmen Leitch

There are about 20,000 genes in the human genome that code for proteins, which are essential to the form and function of our physiology. But those coding regions only make up about two percent of the genome. Once dismissed as 'junk,' researchers are now learning more about the vast, noncoding regions of the genome. Researchers have now found new targets for the treatment of cancer within these areas by using cutting edge genomic sequencing techniques, which have helped them learn more about the regulatory purposes they serve. The findings have been reported in Cancer Cell.

Researcher Dr. Mathieu Lupien, Senior Scientist, Princess Margaret Cancer Centre, knew that these non-coding regions served a purpose, and has devoted his work to learn more about them. "We are exploring uncharted territory," Lupien said. "Our goal is to conquer cancer in our lifetime. We have to look everywhere including the darkest parts of the genome of cancer cells for that hidden gold."

Dr. Lupien led an international team of scientists and clinicians in the analysis of 270,000 mutations that were found in primary prostate tumors. The researchers learned that these genetic errors appear in certain noncoding regions that impact proteins that help control whether gene expression is turned on or off. These proteins, dubbed "the maestro of the cell" by Lupien, can stop prostate cancer cells from growing, which makes them good targets for therapeutics.

Image credit: Public Domain Pictures

This opens up new avenues in cancer therapy, and capitalizes on the data gathered from their analysis of the mutations in both coding and noncoding areas, he said. "Just imagine the possibilities the noncoding genome opens up," he continued.

Noncoding regions have been increasingly recognized for their influence on not only gene expression, but also disease. Lupien explained that millions of switches that affect gene expression are contained in these portions of the genome, and can impact different types of cells throughout the body.

"Now we can start connecting these genetic switches to cancer development to get a more precise understanding of how disease begins and how we can treat it," he added.

Expanding what we know about biomarkers can help improve precision medicine, said Lupien. "The inclusion of the noncoding genome in our analysis is a leap in the right direction to achieve our goal," he concluded.

Sources: AAAS/Eurekalert! via University Health Network, Cancer Cell

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
AUG 28, 2020
Genetics & Genomics
'Jumping' Genes Can Regulate Gene Expression in Human Neurons
AUG 28, 2020
'Jumping' Genes Can Regulate Gene Expression in Human Neurons
Even though genes that code for protein have been an intense focus of biomedical research for decades, the human genome ...
SEP 16, 2020
Genetics & Genomics
Epigenetic Defects Are More Common in People Than Thought
SEP 16, 2020
Epigenetic Defects Are More Common in People Than Thought
The genome still holds many secrets, some of which probably have a direct relationship to human disease. Beyond genes th ...
NOV 10, 2020
Immunology
Genetic Profiling Reveals How Ebola Puts Immune Cells in a Chokehold
NOV 10, 2020
Genetic Profiling Reveals How Ebola Puts Immune Cells in a Chokehold
In the middle of 2020, yet another deadly Ebola outbreak was reported in the Democratic Republic of the Congo - the 11th ...
NOV 10, 2020
Microbiology
New Species of Rocky Mountain Spotted Fever-Causing Bacteria is IDed
NOV 10, 2020
New Species of Rocky Mountain Spotted Fever-Causing Bacteria is IDed
Ticks transmit the bacterial pathogen that causes Rocky Mountain Spotted Fever (RMSF).
NOV 30, 2020
Genetics & Genomics
Green Genetic Technology Can Help Feed the World
NOV 30, 2020
Green Genetic Technology Can Help Feed the World
In the latter half of the last century, agriculture underwent a technological revolution that enabled farmers to create ...
DEC 03, 2020
Cell & Molecular Biology
7 Considerations When Purchasing a Microvolume UV-Vis Spectrophotometer
DEC 03, 2020
7 Considerations When Purchasing a Microvolume UV-Vis Spectrophotometer
It all started with the Thermo Scientific™ NanoDrop™ 1000 as the first microvolume UV-Vis spectrophotometer, ...
Loading Comments...